Pfizer CEO Albert Bourla sold $5.6 million worth of stock on Monday — the same day it said its and BioNTech's coronavirus vaccine showed 90% effectiveness in preliminary results, which saw the company's stock soaring almost 8%.
Between the lines: The stock sale is perfectly legal through a predetermined plan called Rule 10b5-1, but the optics aren't great. A Pfizer spokesperson did not add any new information in a statement, saying the sale was part of a predetermined plan created in August.
